| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ... Neurology 65 (12), 1863-1872, 2005 | 5819 | 2005 |
| Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ... Neurology 89 (1), 88-100, 2017 | 3547 | 2017 |
| The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia JJ Zarranz, J Alegre, JC Gómez‐Esteban, E Lezcano, R Ros, I Ampuero, ... Annals of Neurology: Official Journal of the American Neurological …, 2004 | 3489 | 2004 |
| Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study I McKeith, T Del Ser, PF Spano, M Emre, K Wesnes, R Anand, ... The Lancet 356 (9247), 2031-2036, 2000 | 1563 | 2000 |
| Nonpharmacological therapies in Alzheimer’s disease: a systematic review of efficacy J Olazarán, B Reisberg, L Clare, I Cruz, J Peña-Casanova, T Del Ser, ... Dementia and geriatric cognitive disorders 30 (2), 161-178, 2010 | 1311 | 2010 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1057 | 2022 |
| Social networks, social integration, and social engagement determine cognitive decline in community-dwelling Spanish older adults MV Zunzunegui, BE Alvarado, T Del Ser, A Otero The Journals of Gerontology Series B: Psychological Sciences and Social …, 2003 | 994 | 2003 |
| Poststroke dementia: clinical features and risk factors R Barba, S Martínez-Espinosa, E Rodríguez-García, M Pondal, ... Stroke 31 (7), 1494-1501, 2000 | 689 | 2000 |
| A phase II trial of tideglusib in Alzheimer's disease S Lovestone, M Boada, B Dubois, M Hüll, JO Rinne, HJ Huppertz, ... Journal of Alzheimer's Disease 45 (1), 75-88, 2015 | 500 | 2015 |
| Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study HH Feldman, S Ferris, B Winblad, N Sfikas, L Mancione, Y He, S Tekin, ... The Lancet Neurology 6 (6), 501-512, 2007 | 454 | 2007 |
| Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease J Olazarán, R Muñiz, B Reisberg, J Peña-Casanova, T Del Ser, ... Neurology 63 (12), 2348-2353, 2004 | 437 | 2004 |
| White matter changes on CT and MRI: an overview of visual rating scales P Scheltens, T Erkinjunti, D Leys, LO Wahlund, D Inzitari, T del Ser, ... European neurology 39 (2), 80-89, 1998 | 354 | 1998 |
| Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements P Kapeller, R Barber, RJ Vermeulen, H Ader, P Scheltens, W Freidl, ... Stroke 34 (2), 441-445, 2003 | 347 | 2003 |
| Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study T Del Ser, KC Steinwachs, HJ Gertz, MV Andres, B Gomez-Carrillo, ... Journal of Alzheimer's Disease 33 (1), 205-215, 2013 | 335 | 2013 |
| Trajectories of cognitive decline and social relations F Béland, MV Zunzunegui, B Alvarado, A Otero, T Del Ser The Journals of Gerontology Series B: Psychological Sciences and Social …, 2005 | 333 | 2005 |
| A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ... Movement Disorders 29 (4), 470-478, 2014 | 315 | 2014 |
| Estimation of premorbid intelligence in Spanish people with the Word Accentuation Test and its application to the diagnosis of dementia T Del Ser, JI González-Montalvo, S Martı́nez-Espinosa, ... Brain and cognition 33 (3), 343-356, 1997 | 273 | 1997 |
| Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised … KA Wesnes, IG McKeith, R Ferrara, M Emre, T Del Ser, PF Spano, ... Dementia and geriatric cognitive disorders 13 (3), 183-192, 2002 | 272 | 2002 |
| Frequency of cognitive impairment without dementia in patients with stroke: a two-year follow-up study S Serrano, J Domingo, E Rodríguez-Garcia, MD Castro, T del Ser Stroke 38 (1), 105-110, 2007 | 267 | 2007 |
| Evolution of cognitive impairment after stroke and risk factors for delayed progression T del Ser, R Barba, MM Morin, J Domingo, C Cemillan, M Pondal, ... Stroke 36 (12), 2670-2675, 2005 | 249 | 2005 |
